Current Drug Targets
Title:Meet the Editorial Board Member
Volume: 23 Issue: 2
Author(s): L. Zhang
Affiliation:
Export Options
About this article
Cite this article as:
Zhang L., Meet the Editorial Board Member, Current Drug Targets 2022; 23 (2) . https://dx.doi.org/10.2174/138945012302220118152057
DOI https://dx.doi.org/10.2174/138945012302220118152057 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response and/or therapy ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Gap in Knowledge about Tapering Targeted Therapy being used as
Monotherapy in Rheumatoid Arthritis: A Systematic Review
Current Rheumatology Reviews Anti-Inflammatory Effects of Novel Standardized Platelet Rich Plasma Releasates on Knee Osteoarthritic Chondrocytes and Cartilage in vitro
Current Pharmaceutical Biotechnology Recent Clinical Evidence for the Treatment of Osteoarthritis: What we have Learned
Reviews on Recent Clinical Trials Fc Engineering to Improve the Function of Therapeutic Antibodies
Current Pharmaceutical Biotechnology In-Vitro Assessment and Pharmacodynamics of Nimesulide Incorporated Aloe vera Transemulgel
Current Drug Discovery Technologies Evidence of Association between Epstein Barr Virus Serum Antibodies with HAs and RI as Biomarkers of Active Rheumatoid Arthritis
Current Biomarkers (Discontinued) Molecular Targets in Osteoarthritis: Metalloproteinases and Their Inhibitors
Current Drug Targets Inflammatory Markers in Essential Hypertension: Potential Clinical Implications
Current Vascular Pharmacology Acethylcholinesterase Inhibition, Antibacterial and Antioxidant Properties of Diaryl Oxalates
Current Enzyme Inhibition Antioxidant Activity of 1,2,4-Triazole and its Derivatives: A Mini-Review
Mini-Reviews in Medicinal Chemistry Chloroquine and Hydroxychloroquine as Inhibitors of Human Immunodeficiency Virus (HIV-1) Activity
Current Pharmaceutical Design Novel Action and Mechanism of Auranofin in Inhibition of Vascular Endothelial Growth Factor Receptor-3-Dependent Lymphangiogenesis
Anti-Cancer Agents in Medicinal Chemistry Synthesis, Characterization, Biological Activity and Voltammetric Behavior and Determination of Cefaclor Metal Complexes
Current Analytical Chemistry Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients
Current Drug Targets Antisynthetase Syndrome: A Review of Etiopathogenesis, Diagnosis and Management
Current Medicinal Chemistry Skin Permeation of Nanoparticles: Mechanisms Involved and Critical Factors Governing Topical Drug Delivery
Current Pharmaceutical Design Multiple Sclerosis: Current and Future Treatment Options
Endocrine, Metabolic & Immune Disorders - Drug Targets E-Pharmacophore and Molecular Dynamics Study of Flavonols and Dihydroflavonols as Inhibitors Against DiHydroOrotate DeHydrogenase
Combinatorial Chemistry & High Throughput Screening Zinc and its Specific Transporters as Potential Targets in Airway Disease
Current Drug Targets Development of Infection and Inflammation Targeting Compounds
Current Radiopharmaceuticals